Scientists Just Made CRISPR 3x More Effective at Treating Genetic Diseases
Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat genetic diseases.| Good News Network
Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy| Wyss InstituteWyss Institute
Featuring stories by John Woodrow Cox, Justin Sayles, Aryn Baker, Moran Barkai and Paul Tullis, and Russell Cobb and Sarah Brandvold.| Longreads
Dr. Jeannie Lee wins $1M Blavatnik Award to advance FMR1 gene reactivation therapy for Fragile X, building on years of FRAXA-funded research. The post Harvard’s Dr. Jeannie Lee Wins $1M Award to Develop Gene Reactivation Therapy for Fragile X appeared first on FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome.| FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome
In 2013, scientists showed that CRISPR was able to change the DNA of human cells. This technology has opened doors for finding new treatments for cancer. This article is part of our WinSPIRE Science in the News series. Authors: Helen Diego Jimenez and Dulce Aguilar Cruz| The Pipettepen
Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat genetic diseases.| Good News Network
Abbie (Roth) Miller, MS, MWC, is a passionate communicator of science. As the manager of medical and science content at Nationwide Children’s Hospital, she shares stories about innovative research and discovery with audiences ranging from parents to preeminent researchers and leaders. She is a Medical Writer Certified®, credentialed by the American Medical Writers Association, and received her masters of science in Health Communication from Boston University.| Pediatrics Nationwide
CRISPR-Cas9 gene editing revolutionized biological and biomedical research virtually overnight. The versatile tool has been used to improve crop yields and cure previously uncurable conditions like sickle cell anemia. In May 2025, the Nobel Prize-winning technology brought about another major biomedical breakthrough, as Kiran Musunuru and Rebecca Ahrens-Nicklas introduced the first personalized CRISPR gene editing... The post The CRISPR revolution continues appeared first on Cold Spring Harbo...| Cold Spring Harbor Laboratory
In May, patient Michael Kalberer wrote about why he joined a revolutionary clinical trial where he was only the second person in the world to receive CRISPR gene editing inside the body. Michael recently provided an update on how he’s been doing since, and in what ways his vision has changed. In September 2020, Michael… Read More »CRISPR Gene Therapy Update: Seeing a Sunset The post CRISPR Gene Therapy Update: Seeing a Sunset appeared first on FOCUS.| FOCUS
CRISPR-based gene editing technology Casgevy has been approved for treatment of sickle cell disease and beta-thalassaemia in the NHS| Genomics Education Programme
The following is an excerpt from an article by the NEXT LEVEL: Wem gehört das Leben? – Warum wir Gentechnik stoppen müssen / Who Owns Life? – Why We Must Stop Genetic Engineering. Genetic engineeri…| Critical Check
How a new approach to correcting heterozygous mutations and other novel techniques for gene editing are transforming the potential to combat disease| Pediatrics Nationwide
Investigators from Nationwide Children’s Hospital created fratricide-resistant and metabolically-enhanced chimeric antigen receptor (CAR) natural killer (NK) and T cells that have cytotoxic effects on many hematologic tumors.| Pediatrics Nationwide
Scientists discover new gene editing tools in bacterial "jumping genes" that can be modified to cut, paste, and flip any sequence of DNA.| SingularityHub
Overriding natural evolution, gene drives could add genes that make weeds more vulnerable to herbicides or reduce their pollination and numbers.| SingularityHub
Explore 10 gene therapy companies operating within the biotech industry, as each one hopes to develop their own novel candidates.| Labiotech.eu
Using the safe and sensible CRISPR technology that has the power to help the 300,000 babies born with sickle cell disease each year and the nearly 10 million people estimated to suffer from this genetic disorder globally.| science.thewire.in
de Bailey Kirkpatrick, 28 de fevereiro de 2017 *| IERFH
